The Suitability of P. falciparum Merozoite Surface Proteins 1 and 2 as Genetic Markers for In Vivo Drug Trials in Yemen

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Al abd, Nazeh M ^a,b   Mahdy, Mohammed A K ^a,c,f   Al Mekhlafi, Abdulsalam M Q ^c   Snounou, Georges ^d,e   Abdul Majid, Nazia B ^b   Al Mekhlafi, Hesham M ^a,c   Fong, Mun Y ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c SANA A UNIVERSITY   (Yemen)

^d INSERM   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2;

ARTICLE; CHILD; CLINICAL RESEARCH; CONTROLLED STUDY; DRUG RESEARCH; FEMALE; FEVER; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC ELEVATION; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MSP1 GENE; MSP2 GENE; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SCHOOL CHILD; SCREENING TEST; YEMEN;

ADOLESCENT; ADULT; ALLELES; ANIMALS; ANOPHELES; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; DISEASE VECTORS; FEMALE; GENETIC MARKERS; HETEROZYGOTE; HUMANS; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; MOLECULAR TYPING; PHYLOGEOGRAPHY; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; YEMEN;

PLASMODIUM FALCIPARUM;

EID: 84879820500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067853     Document Type: Article

References (32)

1. WHO (2008) The global burden of disease: 2004 update. Geneva: World Health Organization.
2. Alkadi HO, Al-Maktari MT, Nooman MA, (2006) Chloroquine-resistant Plasmodium falciparum local strain in Taiz Governorate, Republic of Yemen. Chemotherapy 52: 166-170.
3. WHO (2009) World Malaria Report. World Health Organization.
4. NMCP (2002) Malaria Report. Yemen: National Malaria Control Programme.
5. Al-Mekhlafi A, Mahdy M, Azazy A, Fong M, (2010) Clinical situation of endemic malaria in Yemen. Tropical Biomedicine 27: 551-558.
6. Al-Mekhlafi AM, Mahdy MA, Al-Mekhlafi HM, Azazy AA, Fong MY, (2011) High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: An urgent need to re-examine malaria drug policy. Parasit Vectors 4: 94.
7. Al-Maktari MT, Bassiouny HK, Al-Hamd ZS, Assabri AM, El-Massry AG, et al. (2003) Malaria status in Al-Hodeidah Governorate, Yemen: malariometric parasitic survey & chloroquine resistance P. falciparum local strain. J Egypt Soc Parasitol 33: 361-372.
8. Mwingira F, Nkwengulila G, Schoepflin S, Sumari D, Beck HP, et al. (2011) Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa. Malar J 10: 79.
9. WHO (2008) Methods and techniques for clinical trials on antimalarial drug efficacy: Genotyping to identify parasite populations: World Health Organization. 54 p.
10. Ministry of planning and international cooperation Y (2004) National census of Yemen.
11. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, et al. (1999) Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg 93: 369-374.
12. Soulama I, Nebie I, Ouedraogo A, Gansane A, Diarra A, et al. (2009) Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso. Malar J 8: 135.
13. Ariey F, Chalvet W, Hommel D, Peneau C, Hulin A, et al. (1999) Plasmodium falciparum parasites in French Guiana: limited genetic diversity and high selfing rate. Am J Trop Med Hyg 61: 978-985.
14. Takala S, Branch O, Escalante AA, Kariuki S, Wootton J, et al. (2002) Evidence for intragenic recombination in Plasmodium falciparum: identification of a novel allele family in block 2 of merozoite surface protein-1: Asembo Bay Area Cohort Project XIV. Mol Biochem Parasitol 125: 163-171.
15. Kang JM, Moon SU, Kim JY, Cho SH, Lin K, et al. (2010) Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar. Malar J 9: 131.
16. Ghanchi NK, Martensson A, Ursing J, Jafri S, Bereczky S, et al. (2010) Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2. Malar J 9: 1.
17. Babiker HA, Lines J, Hill WG, Walliker D, (1997) Population structure of Plasmodium falciparum in villages with different malaria endemicity in east Africa. Am J Trop Med Hyg 56: 141-147.
18. Haddad D, Snounou G, Mattei D, Enamorado IG, Figueroa J, et al. (1999) Limited genetic diversity of Plasmodium falciparum in field isolates from Honduras. Am J Trop Med Hyg 60: 30-34.
19. Zwetyenga J, Rogier C, Tall A, Fontenille D, Snounou G, et al. (1998) No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg 59: 726-735.
20. Conway DJ, Greenwood BM, McBride JS, (1991) The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients. Parasitology 103 Pt 1: 1-6.
21. Smith T, Beck HP, Kitua A, Mwankusye S, Felger I, et al. (1999) Age dependence of the multiplicity of Plasmodium falciparum infections and of other malariological indices in an area of high endemicity. Trans R Soc Trop Med Hyg 93Suppl 1: 15-20.
22. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F, (2008) Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Malar J 7: 17.
23. Paul RE, Hackford I, Brockman A, Muller-Graf C, Price R, et al. (1998) Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand. Am J Trop Med Hyg 58: 195-203.
24. Babiker HA, Walliker D, (1997) Current views on the population structure of Plasmodium falciparum: Implications for control. Parasitol Today 13: 262-267.
25. Paul RE, Day KP, (1998) Mating patterns of Plasmodium falciparum. Parasitol Today 14: 197-202.
26. Sakihama N, Ohmae H, Bakote'e B, Kawabata M, Hirayama K, et al. (2006) Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Am J Trop Med Hyg 74: 31-40.
27. Zakeri S, Bereczky S, Naimi P, Pedro Gil J, Djadid ND, et al. (2005) Multiple genotypes of the merozoite surface proteins 1 and 2 in Plasmodium falciparum infections in a hypoendemic area in Iran. Trop Med Int Health 10: 1060-1064.
28. Schoepflin S, Valsangiacomo F, Lin E, Kiniboro B, Mueller I, et al. (2009) Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malar J 8: 250.
29. Joshi H, Valecha N, Verma A, Kaul A, Mallick PK, et al. (2007) Genetic structure of Plasmodium falciparum field isolates in eastern and north-eastern India. Malar J 6: 60.
30. Mubjer RA, Adeel AA, Chance ML, Hassan AA, (2011) Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications. Malar J 10: 245.
31. Greenhouse B, Myrick A, Dokomajilar C, Woo JM, Carlson EJ, et al. (2006) Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. Am J Trop Med Hyg 75: 836-842.
32. Daniels R, Volkman SK, Milner DA, Mahesh N, Neafsey DE, et al. (2008) A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking. Malar J 7: 223.